Literature DB >> 18423943

Molecular modeling and inhibition of phospholipase A2 by polyhydroxy phenolic compounds.

S L da Silva1, A K Calgarotto, V Maso, D C S Damico, P Baldasso, C L Veber, J A F P Villar, A R M Oliveira, M Comar, K M T Oliveira, S Marangoni.   

Abstract

Phospholipases A(2) are enzymes responsible for the hydrolysis of membrane phospholipids that release arachidonic acid, which serves as substrate for pro-inflammatory mediators, such as prostaglandins and leucotriens. The design of specific inhibitors for PLA(2) might help in the development of new anti-inflammatory drugs. Polyhydroxy phenolic compounds, such as flavonoids, vitamin E, rosmarinic acid and aristolochic acid, are able to inhibit PLA(2) from different sources. Herein, we have studied the kinetic behavior and the capacity of inhibiting edema formation induced by PLA(2) of five different polyhydroxy phenolic compounds (two phenolic derivatives and three acetophenone hydroxylated derivatives) extracted from the venom of Crotalus adamanteus. The results showed that compounds 1,3-dihydroxy benzene, 1,3,5-trihydroxy benzene and 2,4,6-trihydroxy acetophenone were the most efficient in the inhibition of the enzymatic activity and edema induction by PLA(2). It was also verified that the number of hydroxyls in each molecule is not a limiting factor for the inhibition capacity of these compounds. Molecular modeling studies indicated that the most active compounds are linked to the amino acid Asp 49 and that they destabilize the coordination of the calcium atom, which is essential to the catalytic activity. The study of potential surfaces showed that there are conditions in which the potential values must be adequate for enzyme complex formation with polyhydroxy phenolic compounds. When the potential over the hydroxyl surfaces is very high, formation of stable complexes does not occur and the enzyme does not act intensely. These results might be helpful in the design of a drug that specifically inhibits PLA(2).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423943     DOI: 10.1016/j.ejmech.2008.02.043

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  12 in total

1.  Inhibitory effects of bile acids on enzymatic and pharmacological activities of a snake venom phospholipase A(2) from group IIA.

Authors:  Jaime Andrés Pereañez; Vitelbina Núñez; Arley Camilo Patiño
Journal:  Protein J       Date:  2011-04       Impact factor: 2.371

2.  Problems with molecular mechanics implementations on the example of 4-benzoyl-1-(4-methyl-imidazol-5-yl)-carbonylthiosemicarbazide.

Authors:  Agata Siwek; Katarzyna Swiderek; Stefan Jankowski
Journal:  J Mol Model       Date:  2011-05-28       Impact factor: 1.810

Review 3.  Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease.

Authors:  Agnes Simonyi; Yan He; Wenwen Sheng; Albert Y Sun; W Gibson Wood; Gary A Weisman; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2010-03-02       Impact factor: 5.590

Review 4.  Polyphenols: a route from bioavailability to bioactivity addressing potential health benefits to tackle human chronic diseases.

Authors:  Silvia Vivarelli; Chiara Costa; Michele Teodoro; Federica Giambò; Aristidis Michael Tsatsakis; Concettina Fenga
Journal:  Arch Toxicol       Date:  2022-10-19       Impact factor: 6.168

5.  Protection against LPS-induced cartilage inflammation and degradation provided by a biological extract of Mentha spicata.

Authors:  Wendy Pearson; Ronald S Fletcher; Laima S Kott; Mark B Hurtig
Journal:  BMC Complement Altern Med       Date:  2010-05-11       Impact factor: 3.659

6.  Carbon monoxide inhibits the anticoagulant activity of phospholipase A2 purified from Crotalus adamanteus venom.

Authors:  Vance G Nielsen
Journal:  J Thromb Thrombolysis       Date:  2019-01       Impact factor: 2.300

7.  In vitro study of the PLA2 inhibition and antioxidant activities of Aloe vera leaf skin extracts.

Authors:  Maher Kammoun; Sonia Miladi; Yassine Ben Ali; Mohamed Damak; Youssef Gargouri; Sofiane Bezzine
Journal:  Lipids Health Dis       Date:  2011-02-11       Impact factor: 3.876

Review 8.  Snake venom PLA2s inhibitors isolated from Brazilian plants: synthetic and natural molecules.

Authors:  B M A Carvalho; J D L Santos; B M Xavier; J R Almeida; L M Resende; W Martins; S Marcussi; S Marangoni; R G Stábeli; L A Calderon; A M Soares; S L Da Silva; D P Marchi-Salvador
Journal:  Biomed Res Int       Date:  2013-09-22       Impact factor: 3.411

9.  Alkylation of histidine residues of Bothrops jararacussu venom proteins and isolated phospholipases A2: a biotechnological tool to improve the production of antibodies.

Authors:  C L S Guimarães; S H Andrião-Escarso; L S Moreira-Dill; B M A Carvalho; D P Marchi-Salvador; N A Santos-Filho; C A H Fernandes; M R M Fontes; J R Giglio; B Barraviera; J P Zuliani; C F C Fernandes; L A Calderón; R G Stábeli; F Albericio; S L da Silva; A M Soares
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

10.  A novel phospholipase A2 (D49) from the venom of the Crotalus oreganus abyssus (North American Grand canyon rattlesnake).

Authors:  W Martins; P A Baldasso; K M Honório; V G Maltarollo; R I M A Ribeiro; B M A Carvalho; A M Soares; L A Calderon; R G Stábeli; M A O Caballol; G Acosta; E Oliveira; S Marangoni; F Albericio; S L Da Silva
Journal:  Biomed Res Int       Date:  2014-02-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.